The U.S. Reported a Record 93,000 Drug Overdose Deaths During the 2020 Pandemic Year

(NEW YORK) — Overdose deaths soared to a record 93,000 last year in the midst of the COVID-19 pandemic, the U.S. government reported Wednesday. That estimate far eclipses the high of about 72,000 drug overdose deaths reached the previous year and amounts to a 29% increase. “This is a staggering loss of human life,” said Brandon Marshall, a Brown University public health researcher who tracks overdose trends. The nation was already struggling with its worst overdose epidemic but clearly “COVID has greatly exacerbated the crisis,” he added. Lockdowns and other pandemic restrictions isolated those with drug addictions and made treatment harder to get, experts said. [time-brightcove not-tgx=”true”] Jordan McGlashen died of a drug overdose in his Ypsilanti, Michigan, apartment last year. He was pronounced dead on May 6, the day before his 39th birthday. “It was really difficult for me to think about the way in which Jordan died. He was alone, and suffering emotionally and felt like he had to use again,” said his younger brother, Collin McGlashen, who wrote openly about his brother’s addiction in an obituary. Jordan McGlashen’s death was attributed to heroin and fentanyl. While prescription painkillers once drove the nation’s overdose epidemic, they were supplanted first by heroin and then by fentanyl, a dangerously powerful opioid, in recent years. Fentanyl was developed to treat intense pain from ailments lik...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Addiction COVID-19 wire Source Type: news

Related Links:

Immune checkpoint inhibitors can be effective in patients with non-small cell lung cancer and mild interstitial lung disease, but with a greater risk.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Pulmonary Medicine News Source Type: news
AbstractPurposeGenetic variants may influence the pharmacokinetics and pharmacodynamics (PKPD) of cyclophosphamide (CY). CY plays a critical role in conditioning chemotherapy for hematopoietic cell transplantation (HCT), but its use is limited by toxicity. We explored the effect of genetic variants, potentially affecting PKPD of CY, and outcomes after HCT.MethodsThis observational pharmacogenomic study included 85 adults with hematologic malignancies who received reduced intensity conditioning with CY, fludarabine, and total body irradiation. We collected recipient DNA prior to HCT and evaluated 97 candidate variants in 66...
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
Oncogene, Published online: 27 January 2022; doi:10.1038/s41388-021-02158-wSELENOF is a new tumor suppressor in breast cancer
Source: Oncogene - Category: Cancer & Oncology Authors: Source Type: research
This article is licensed under aCreative Commons Attribution 3.0 Unported Licence.Mariana Rodriguez-Hakim, Linard R äz, Jan Vermant Some contagious diseases, such as COVID-19, spread through the transmission of aerosols and droplets. Aerosol and droplet formation occurs inside and outside of the respiratory tract, the latter being observed... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Soft Matter latest articles - Category: Chemistry Authors: Source Type: research
Dalton Trans., 2022, Accepted Manuscript DOI: 10.1039/D1DT04315C, PaperXiang Wang, Kang Song, Yong Deng, Jie Liu, Qin Peng, Xiao Lao, Jiayu Xu, Dong Wang, Turong Shi, Yuhao Li, Dan Deng, Yuqing Miao Photodynamic therapy (PDT) is an effective non-invasive treatment for tumors. The structure of the photosensitizer has an important influence on the light utilization and the efficiency of singlet-oxygen generation. In... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Dalton Trans. latest articles - Category: Chemistry Authors: Source Type: research
Chem. Commun., 2022, Advance Article DOI: 10.1039/D1CC06330H, CommunicationXiao-Jie Dong, Wen-Yan Li, Qun Guan, Yan-An Li, Yu-Bin Dong A COF-based multifunctional nanomedicine CuS@COF-BDP, which can be used as a PTT/PDT bimodal therapeutic agent to inhibit cancer cell proliferation under visible- and NIR-II-light irradiation, is reported. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Chem. Commun. latest articles - Category: Chemistry Authors: Source Type: research
Abbott Laboratories has distributed more than 1.4 billion Covid-19 tests globally since the start of the pandemic, including around 300 million in the fourth quarter of 2021. Its global Covid-19 testing-related sales were $2.3 billion in the fourth quarter and $7.7 billion for the full year in 2021.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
The recent surge in drug overdose deaths shocked even some of the most jaded observers of American addiction: 100,306 dead from April 2020 to April 2021, the first time the toll topped six figures in a 12-month period, according to provisional data from the National Center for Health Statistics. New data released yesterday by the U.S. Centers for Disease Control and Prevention (CDC) point to one potential culprit: illegally manufactured fentanyl, a synthetic opioid that can be 50 times more potent than heroin. When used legally, with a doctor’s prescription, this class of drugs is meant to help people experiencing se...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Addiction healthscienceclimate Source Type: news
Digital media&downloads Compound Developed at UArizona Health Sciences Provides Innovative Pain Relief Researchers targeted a common sodium ion channel to reverse pain and saw positive results that could lead to a nonaddictive solution to treat pain. Today University of Arizona Health Sciencespain-relief-web.jpgHealthBIO5College of Medicine - TucsonExpertsResearch Media contact(s)Stacy Pigott University of Arizona Health Sciencesspigott@arizona.edu520-539-4152Researchers at the  University of Arizona Health Sciences are closer to developing a safe and effective non-opioid pain reliever after a study showed t...
Source: The University of Arizona: Health - Category: Universities & Medical Training Authors: Source Type: research
ConclusionDespite being turned back from an effort to bluntly reduce opioid prescribing by the FDA in 2013 based on a lack of scientific evidence for its position (17,18), PROP has had a disproportionate effect on opioid policy in the Untied States for almost a decade. PROP found a willing federal regulatory partner in the CDC, and while PROP may not have “secretly written” the 2016 CDC Pain Guidelines (75), they certainly enjoyed disproportionate representation on CDC’s review panels and Core Expert Group (23-25) in a process that lacked transparency (22, 23, 26, 27). When the CDC admitted that its Pain ...
Source: Pallimed: A Hospice and Palliative Medicine Blog - Category: Palliative Care Tags: CDC health policy kollas opioids pain prop Source Type: blogs
More News: Addiction | Cancer | Cancer & Oncology | Centers for Disease Control and Prevention (CDC) | COVID-19 | Education | Epidemics | Epidemiology | Fentanyl | Government | Health | History of Medicine | International Medicine & Public Health | Jordan Health | Methamphetamine | Middle East Health | Overdose | Pain | Pandemics | Science | Unemployment | Universities & Medical Training